Sino Biological,Inc. (SHE:301047)
China flag China · Delayed Price · Currency is CNY
91.92
-7.28 (-7.34%)
Nov 16, 2026, 4:00 PM EST

Sino Biological,Inc. Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
791.99699.56613.67646.39574.6965.27
Revenue Growth
19.97%14.00%-5.06%12.49%-40.47%-39.53%
Gross Profit
581.35509.09442.69520.54479.59896.29
Operating Income
131.9290.2129.29135.76203.53696.56
Net Income
179.07147.74121.93260.13302.96720.01
Earnings Per Share
1.471.210.952.012.666.69
EPS Growth
36.94%27.45%-52.67%-24.30%-60.22%-42.53%

Revenue by Geography

Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '24 Dec '23 Jan '23
China
321.07259.31245.27224.97
Overseas
378.5354.36401.11349.63
Total
699.56613.67646.39574.6

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
2,9633,2223,9494,8495,8026,511
Total Debt
41.1453.5267.3785.0670.4647.36
Net Cash (Debt)
2,9213,1693,8824,7645,7326,463
Net Cash Growth
-8.98%-18.38%-18.51%-16.89%-11.32%472.58%
Net Cash Per Share
24.0226.0530.3436.8750.3260.03

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
214.3146.19113.73322.56249.39642.62
Capital Expenditures
-159.42-101.05-69.95-1,043-156.06-47.9
Free Cash Flow
54.8945.1443.78-720.893.34594.72
Free Cash Flow Growth
26.61%3.10%---84.31%-44.66%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
73.40%72.77%72.14%80.53%83.47%92.85%
Operating Margin
16.66%12.90%4.77%21.00%35.42%72.16%
Pretax Margin
27.14%25.66%23.03%44.55%59.61%87.59%
Profit Margin
22.61%21.12%19.87%40.24%52.73%74.59%
FCF Margin
6.93%6.45%7.13%-111.51%16.24%61.61%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
2.0005.2001.0002.0002.0005.263
Dividend Per Share Growth
-56.00%420.00%-50.00%0%-62.00%-
Dividend Yield
2.18%7.69%1.62%2.43%2.01%2.89%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
62.4455.6661.7040.9342.5032.65
Forward PE
55.0452.8142.2234.4138.7820.76
P/FCF Ratio
203.71182.15171.82-137.9539.53
PS Ratio
14.1211.7512.2616.4722.4124.35